Vigilare Biop

Vigilare Biop adicionou um novo artigo Outro
2026-05-13 09:16:37 -

Pharmacovigilance in India: Understanding CDSCO’s Regulatory Framework
India’s pharmaceutical industry is on a fast growth trajectory, making drug safety oversight more critical than ever. At the center of this effort is the Central Drugs Standard Control Organization (CDSCO), which defines the country’s pharmacovigilance (PV) standards and ensures patient safety throughout a drug’s lifecycle. Strengthened Pharmacovigilance Requirements In 2026,...

0 Comentários 0 Compartilhamentos 109 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Vigilare Biop adicionou um novo artigo Outro
2026-04-08 06:39:09 -

A Practical Guide to US Pharmacovigilance Submission Documents
Pharmacovigilance ensures that drug safety monitoring continues beyond market approval. In the U.S., sponsors must prepare US Pharmacovigilance Submission Documents to meet FDA compliance. PV Plan and REMS A robust plan defines risks, missing information, and mitigation strategies, aligned with ICH E2E guidance. A REMS may be required for high-risk drugs, bridging patient safety and regulatory...

0 Comentários 0 Compartilhamentos 137 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Vigilare Biop adicionou um novo artigo Outro
2026-04-08 06:28:18 -

The Strategic Value of Regulatory Affairs in Pharma Development
Bringing a drug to market requires careful scientific planning and regulatory compliance. Regulatory affairs ensures innovations comply with global requirements, making it a central function. Early Engagement Ensures Alignment Engaging regulatory professionals early allows for better study design, risk mitigation, and identification of the optimal regulatory pathway. Specialists guide sponsors...

0 Comentários 0 Compartilhamentos 120 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Vigilare Biop adicionou um novo artigo Outro
2026-03-03 06:29:59 -

EU Pharmacovigilance Documentation for Emerging Biotech Companies
For biotech startups, entering Europe requires structured safety governance. The European Medicines Agency expects robust systems regardless of company size. Startups can explore our comprehensive overview of pharmacovigilance documents required in Europe. Core requirements remain: PSMF RMP PSUR PASS EudraVigilance registration PRAC review processes apply equally to all MAHs....

0 Comentários 0 Compartilhamentos 190 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Vigilare Biop atualizou a foto de perfil
2026-01-27 04:45:45 -

0 Comentários 0 Compartilhamentos 123 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!

Mais Stories